LYRM4 and colon adenocarcinoma: As shown in Fig. 10d, LYRM4 mRNA was significantly overexpressed in colon adenocarcinoma (COAD), head and neck cancer (HNSC), kidney renal papillary cell carcinoma (KIRP), LIHC, lung squamous cell carcinoma (LUSC), and prostate adenocarcinoma (PRAD; p < 0.001).